Clinical trial
Polarization Enhanced Wide Field Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers
NCT02666833 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Polarization Enhanced Wide Field Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2016
- Completion date
- August 31, 2017
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, basal cell, carcinoma, squamous cell